Daily as of 3 Nov 16:00 ET
- Price
- below both $16.63 vs 50 $16.64 / 200 $22.83
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 16 Sep 2026 · projected 8 bars out
RARE | Ultragenyx PharmaceuticalNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$16.63
+$0.33 (+2.02%)
Ultragenyx Pharmaceutical (RARE) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits below the 50 and the 200; on the 4-hour it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $16.10 vs 50 $24.18 / 200 $37.46
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 20 Jun 2022 · projected 16 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $16.86 vs 50 $15.56 / 200 $22.52
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 24 Aug 2026 bar 2 · projected 22 bars out · tested 7 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 16 Sep 2026 | 💀Death steep | daily | 8 bars out | Not tested |
| 24 Aug 2026 | 💀Death | 4-hour | 22 bars out | 7 bar cross test |
| 20 Jul 2026 | 🟨Golden steep | daily | 30 bars out | 5 bar cross test |
| 7 May 2026 | 🟨Golden | 4-hour | 30 bars out | Not tested |
| 8 Jan 2026 | 💀Death | 4-hour | 11 bars out | Not tested |
About RARE
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$58.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall